Our UTI LITE w/AMR panel includes detection of key bacterial pathogens such as Enterococcus spp., Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Staphylococcus aureus, Staphylococcus saprophyticus, and Pseudomonas aeruginosa. Additionally, it screens for critical antimicrobial resistance markers, including Methicillin/Oxacillin (mecA) and Vancomycin (vanA & vanB). This dual detection capability allows healthcare providers to identify the causative agents of UTIs and assess their resistance profiles, ensuring that the chosen treatment is both effective and targeted.

The ability to detect antibiotic-resistant strains is crucial in managing UTIs, as it helps prevent the misuse of antibiotics and supports the use of appropriate antimicrobial therapies. With the Express Gene™ UTI LITE w/AMR test, you receive a comprehensive and reliable diagnostic tool that enhances patient care by delivering precise and actionable information on both infection and resistance.